Quick Links: Bupropion; Carbidopa/Levodopa/Entacapone; Chlorpromzine; Duloxetine; Niacin; Compounded Semaglutide; Tylenol
Drug Recall: Bupropion Hydrochloride Extended-Release Tablets XL (Wellbutrin XL generic) by Graviti Pharmaceuticals
Graviti Pharmaceuticals is recalling 46,512
bottles of Bupropion Hydrochloride Extended-Release Tablets XL,
300 mg strength (30-count), distributed and packaged by Rising
Pharma. The recall was triggered due to failure in critical
quality control specifications. Bupropion XL, a generic for
Zyban, is prescribed to help patients
quit smoking. Bupropion is
also used as an antidepressant. These tablets were
manufactured in Sangareddy, Telangana, India. See the FDA Check
the lot numbers using the FDA announcement.
Recall Announcement
Read or add patient reviews for Bupropion HCL XL (Wellbutrin XL) or Zyban
Rising Pharma Holdings
is recalling 2,064 bottles of Carbidopa, Levodopa, and Entacapone
tablets, 25 mg/100 mg/200 mg strength, 100-count bottles.
Manufactured by Suven Pharmaceuticals Limited in Telangana,
India, the recall follows complaints of product mix-up where some
bottles labeled with the lower strength contained tablets of a
higher strength (37.5 mg/150 mg/200 mg). The tablets are used for
Parkinson’s disease. See FDA recall announcement for affected
lots and dates. Major Pharmaceuticals is
recalling 2,064 blister packs of Chlorpromazine Hydrochloride
Tablets, 25 mg strength, 50 tablets per pack. Formerly branded as
Thorazine, the tablets treat schizophrenia and mood disorders.
The recall resulted from nitrosamine impurities exceeding FDA
limits, which can increase cancer risk. Manufacturing location
was not specified. Check the recall announcement for detailed lot
and expiration information. Breckenridge Pharmaceutical is recalling 172,263 bottles of
antidepressant Duloxetine Delayed-Release Capsules, 60 mg
strength (90-count and 1,000-count), manufactured by Towa
Pharmaceutical Europe, Barcelona, Spain. The recall was due to
nitrosamine impurities above FDA limits, a potential
cancer risk. Refer to the FDA recall announcement for specific
lot numbers and expiration dates. Read or add patient reviews for
Cymbalta (has more than 2,700 reviews) or
Duloxetine
Lannett Company is recalling
46,848 bottles of Niacin Extended-Release Tablets, 1,000 mg
strength (90-count). The products failed dissolution
specifications, which may impact their effectiveness by not
dissolving properly after storage. Niacin is used to manage
cholesterol levels. See the announcement for lot numbers and
expiration dates.
Read or add patient reviews for
Niacin or brand name
NIASPAN ProRx LLC, a licensed compounding pharmacy in
Exton, Pennsylvania, is recalling more than 36,000 multidose
vials of semaglutide and 2,761 vials of tirzepatide distributed
primarily in Texas and Utah. Both drugs are used to treat type 2
diabetes and obesity. The recall was issued due to lack of
assurance of sterility. GenoGenix LLC, a compounding pharmacy in Boca Raton, FL, has
recalled multiple compounded injectable medications, including
semaglutide, tirzepatide, retatrutide, semaglutide with vitamin
B12, and 54 other products such as vitamin blends. The recall was
due to lack of assurance of sterility. Note that retatrutide is
an experimental drug not approved for compounding use and is
associated with obesity treatment. The recall began July 30,
2025, but FDA just recently classified it in October 2025 as a
class II recall. Kenvue Brands is recalling 3,816 bottles
of Acetaminophen 500 mg caplets, 24-count, distributed by Johnson
& Johnson Consumer Inc., McNeil Consumer Healthcare Division. The
recall is due to defective containers. Tylenol is a commonly used
pain reliever and fever reducer. Read or add patient reviews for
Note: Recall information is from FDA Enforcement Reports,
which are linked. Check the announcements for specific lot
numbers and expiration dates. The recalls on this page are
classified as
Class II
level, the middle urgency type of recall because the probability of serious adverse health consequences is remote. The recalls are also
directed at the supplier level, not the consumer, but consumers
may want to check the announcements to make sure they do not have
product that was distributed prior to the recall announcement. Drug Recall: Carbidopa, Levodopa,
Entacapone Tablets by Rising Pharma
Recall AnnouncementDrug Recall: Chlorpromazine Hydrochloride
Tablets by Major Pharmaceuticals
Recall AnnouncementDrug Recall: Duloxetine Delayed-Release
Capsules (Cymbalta generic) by Breckenridge Pharmaceutical
Recall Announcement Drug Recall: Niacin Extended-Release
Tablets by Lannett Company
Recall AnnouncementDrug Recall: Compounded Semaglutide & Tirzepatide by
ProRx LLC
Recall AnnouncementDrug Recall: Compounded Semaglutide, Tirzepatide,
Retatrutide, and Vitamin Injectables by GenoGenix LLC
Recall AnnouncementDrug Recall: Tylenol (Acetaminophen 500 mg)
by Kenvue Brands, LLC
Recall Announcement
